Culture

Making protein 'superfood' from marine algae

image: The Flinders University Centre for Marine Bioproducts Development bioreactor and processed microalgae sample held by Professor Wei Zhang, who is co-leading a bid to establish a national Marine Bioproducts Cooperative Research Centre (MB-CRC) in Australia.

Image: 
Flinders University

Marine microalgae-based cellular agriculture is a promising new way to sustainably produce plant-based 'meat' and healthy 'superfoods' for the future.

Researchers at Flinders University's Centre for Marine Bioproducts Development (CMBD) in Australia are responding to growing interest from consumers looking for healthier, more environmentally friendly, sustainable and ethical alternatives to animal proteins.

Marine microalgae, single-cell photosynthetic organisms from the ocean could be the solution to the world's meat protein shortage, says CMBD director Flinders University Professor Wei Zhang, who is also co-leading a bid to establish a national Marine Bioproducts Cooperative Research Centre (MB-CRC) in Australia.

The CRC's mission is to find ways to develop the third-generation of Australian high-value marine bioindustry (as opposed to the first-generation of fisheries and the second-generation of aquaculture) and transform Australia's emerging marine bioproducts sector into a globally competitive industry.

The Centre's focus will be on industry and market-driven innovations to improve both the supply chain and value chain to deliver costs savings, improved production and competitive capacity for Australia to access high value marine bioproducts markets across the globe.

"Our research spans the entire value chain, from microalgae cultivation and circular advanced biomanufacturing to the development of high-value functional food," Professor Zhang says.

"Microalgae come in a diverse range of nutritional profiles and advanced cultivation strategies can be developed for tuning microalgae to produce protein-, oil- and carbohydrate-dominant types that can be processed into a broad range of functional foods, including healthy cell patties, chips, pastes, jams and even caviar."

Two freshwater microalgal products currently on the market are the high protein Chlorella and Spirulina varieties used in the production of foods such as green pasta, drinks and beverages.

Marine species are of significant interest as they do not require scarce freshwater and crop land. Their unique nutritional profiles such as their high DHA and EPA content (long chain omega 3 fatty acids) are essential for infant and brain development and cardiac health.

Bioreactors for upscaling upscaled aquatic production of photosynthetic microalgae can also help to combat greenhouse gas emissions and climate change. One 90 x 90 x 210 cm (3 x 3 x 7 ft) bioreactor unit can absorb up to 400 times more carbon dioxide than the same footprint of trees.

Using sunlight, certain varieties of microalgae create oxygen and convert carbon dioxide into organic carbon (protein, carbohydrates, pigments, fats and fibres), just like plants, but do not require valuable arable land for their production.

"They are therefore often called the rainforests of the oceans," says Associate Professor Kirsten Heimann, senior lecturer in biotechnology at Flinders University.

"Using sunlight, photosynthetic microalgae create oxygen and convert carbon dioxide into organic carbon (protein, carbohydrates, pigments, fats, fibres, and micronutrients), just like plants, but do not require valuable arable land for their production.

This means microalgae can be sustainably harvested and converted into eco-friendly superfoods," she says. "Putting one and one together, microalgae and innovative production and processing could help to service the world's booming population and growing demand for sustainable protein production," she says.

Along with research into processing techniques, the CMBD team is also investigating the use of waste or harvested seaweed for biodegradable plastics production, another sustainable solution to non-degradable petroleum-based plastics.

Credit: 
Flinders University

Food insecurity spiked during early months of pandemic

Food insecurity spiked among residents living in two predominantly African American neighborhoods during the first weeks of the coronavirus pandemic, far outpacing food insecurity observed among the general U.S. population during the same period, according to a new RAND Corporation study.

Following residents of two Pittsburgh low-income African American neighborhoods characterized as food deserts since 2011, the study found that the pandemic increased the number of people facing food insecurity by nearly 80%.

Similar to United States national trends, food insecurity among residents had been improving consistently since 2011. However, the study found that those gains were erased by the pandemic, with the disparities between the predominantly African American residents and U.S. population at the highest levels seen over the past decade.

The findings are published online by the American Journal of Public Health.

"In a short period of time, the coronavirus pandemic has magnified preexisting racial and ethnic disparities in food security," said Tamara Dubowitz, the study's lead author and a senior policy researcher at RAND, a nonprofit research organization. "While food insecurity is linked to a wide variety of health problems, these disparities reflect larger systemic issues including structural racism."

The study involved residents of the Hill and Homewood neighborhoods in Pittsburgh that have been the focus of a long-running research project investigating the influence that diet, access to food and other items have on residents' health and wellbeing.

Both of the neighborhoods are primarily African American and low income. A group of residents of both areas have been surveyed about their access to healthy food on several occasions since 2011.

For the latest study, RAND researchers surveyed a group of 605 residents from the neighborhoods during March, April and May 2020, asking about how the pandemic was affecting their access to food. Researchers have been following the residents since 2011.

The study found that the number of residents reporting food insecurity increased from 20.7% in 2018 to 36.9% in 2020 -- a nearly 80 percent rise. Previous research had shown that food insecurity had been falling in the two neighborhoods since 2011.

Among those surveyed, participation in the Supplemental Nutrition Assistance Program or SNAP (52.2%) and food bank use (35.9%) did not not change significantly during the early weeks of the coronavirus pandemic.

"This finding suggests that existing safety nets may need more support in order to reach those with emerging needs," Dubowitz said. "Lack of reported use could be due to difficulties with SNAP enrollment, problems accessing food banks in the early days of the pandemic or feelings of stigma related to participating in such programs."

Credit: 
RAND Corporation

Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19

What The Study Did: This randomized clinical trial compares the effects of three doses of bamlanivimab monotherapy (700 vs 2,800 vs 7,000 mg) vs combination bamlanivimab and etesevimab vs placebo on change in day 11 severe acute respiratory syndrome coronavirus 2 viral load in patients with mild to moderate COVID-19.

Authors: Daniel M. Skovronsky, M.D., Ph.D., of Eli Lilly and Company in Indianapolis, is the corresponding author.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jama.2021.0202)

Editor's Note: The articles includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Credit: 
JAMA Network

CNIO participates in a study that defines the most important genes that increase breast cancer risk

image: From left to right, CNIO researchers Belén Herráez, Anna González-Neira, Rosario Alonso, Nuria Álvarez, Ana Osorio, Rocío Núñez, Guillermo Pita, and Javier Benítez

Image: 
A. Garrido, CNIO

Genetic inheritance affects the likelihood of developing breast cancer. Some genes are already known to increase cancer risk; other genes are suspected to be involved, but not to what extent. It is crucial to clarify this issue to improve prevention since it opens the way to more personalised follow-up and screening programs. A large international consortium, which includes the Spanish National Cancer Research Centre (CNIO), has studied 34 putative susceptibility genes on samples from 113,000 female breast cancer cases and controls, and its results confirm the importance of nine of them.

The study "defines the genes most clinically useful for inclusion on panels for breast cancer risk prediction (...), to guide genetic counselling," the authors write in the New England Journal of Medicine (NEJM).

This is the most ambitious study carried out to date to shed light on the role of heredity in breast cancer, one of the most common cancers today - one out of every eight women will have it at some point in their lives.

250 researchers from dozens of institutions in more than 25 countries participated in the genetic analysis. One-third of the samples were analysed at the CNIO, with the participation of Javier Benítez, Anna González-Neira and Ana Osorio. Groups from seven other Spanish institutions also participated in the study.

Osorio, from the CNIO Human Genetics Group, stresses the importance of the information provided by this study when monitoring breast cancer patients and their families. "Genetic tests are already done on people with a family history of the disease, but in those tests we can only analyse genes of which we are certain that they affect the risk. Now we have more information, and we can improve the genetic counselling of patients and their families," the CNIO researcher says.

Low- and moderate-risk genes

It has been known for some time that the risk of developing breast cancer depends partly on genetic inheritance, but determining exactly which genes increase this risk, and how much, remains a major challenge.

The genes that confer high risk when mutated, BRCA1 and BRCA2, were already identified in the mid-1990s. Having mutations in these genes confers a cumulative risk of around 70% of developing breast cancer by the age of 80, and a risk of 40% and 20% of developing ovarian cancer for carriers of mutations in BRCA1 and BRCA2, respectively. It was this strong effect that made it possible to identify these genes in families with a high incidence of cancer.

Today, genetic diagnosis alerts many patients' family members, who can then act at very early stages of cancer or even prevent its appearance. But the BRCA genes explain only a small part of all cases. In the vast majority of cases, genes are involved that confer a lower risk and that may interact with each other or with other genetic and environmental factors, which can modify the risk.

In recent years, a number of studies have identified dozens of such candidate genes that increase the risk of breast cancer to some degree, but these studies were done with relatively few patients and their results were not conclusive. It was the aim of the study now published to improve this knowledge by determining precisely which genes are involved, and to what extent they affect the risk to develop which subtype of tumour.

"Genetic testing for breast cancer susceptibility is widely used, but for many genes the evidence for association with breast cancer is weak," the authors write in NEJM, adding that the risk estimates are imprecise and that cancer subtype-specific risk estimates are lacking altogether.

"The most clinically useful genes"

The study is the result of the European project BRIDGES (Breast Cancer Risk after Diagnostic Gene Sequencing), in which the CNIO participates. The study was based on the analysis of 34 known or suspected breast cancer susceptibility genes in DNA samples from 60,400 women who had developed breast cancer and 53,400 healthy women.

The results pinpoint nine genes for which there is solid evidence of their involvement in the disease: ATM, BRCA1, BRCA2, CHEK2, PALB2, BARD1, RAD51C, RAD51D and TP53. For some of these genes, this was already known, but for others, such as RAD51C and D and BARD1, their involvement was not so well established. For all genes, more precise risk estimates can now be calculated and these estimates are tailored for each tumour subtype.

On the other hand, the study shows that about fifteen of the genes that have been used so far in some tests "are not indicative of an increased risk" for breast cancer and should therefore not be taken into account, at least at this time, in risk estimates.

However, the authors remind us that the probability of developing breast cancer is not determined by genes alone. Other risk factors such as age, hormonal history and environmental factors also play a role, which in turn are influenced by the genetic background.

"In fact," points out González-Neira, Head of the Human Genotyping - CEGEN Unit at the CNIO, "it is been already working on mathematical models that integrate current knowledge about all these factors and their interaction, which make possible to provide a good estimate of the adjusted risk for each woman and thus individualise clinical management".

The final objective is to improve prevention with much more personalised screening programmes than those currently available. Implementation of such precision medicine protocols in breast cancer will improve early diagnosis and reduce morbidity and mortality rates for this disease.

Credit: 
Centro Nacional de Investigaciones Oncológicas (CNIO)

Ten suggestions for female faculty and staff during the pandemic

image: Padmini Rangamani, a professor at the University of California San Diego, is one of the coauthors of Ten simple rules for women principal investigators during a pandemic.

Image: 
University of California San Diego

When university campuses sent students, staff and faculty members home in March, Padmini Rangamani, a professor at the University of California San Diego, suddenly found herself running her research lab remotely, teaching her classes online, and supervising her two children, ages 10 and 13, who are also learning online.

To deal with the stress the situation created, Rangamani turned to a support network of fellow female faculty members around the United States. They chatted and texted and eventually decided to write a scholarly article with recommendations for all other female principal investigators in academia.

The article, "Ten simple rules for women principal investigators during a pandemic," was published October 2020 in PLOS Computational Biology. It's perhaps important to note that despite its title, the article is careful to say that the cardinal rule is that there are no rules. So all 10 points outlined are in fact suggestions. Also despite its title, Rangamani says most of the 10 points outlined in the publication can apply to all caregivers juggling work and caregiving during the pandemic.

"Without in-person school or daycare, and without after-school programs, there is really no way for caregivers to function at full capacity at work," Rangamani said.

In addition, such concerns have not been discussed openly in the workplace, the authors felt. Their real fear is then that talent nurtured through the years will be lost in one fell swoop--and their main goal is to try and change this. Rangamani and fellow co-authors want to normalize conversations about juggling work and family obligations. "If you want to say 'I can't meet at this time, because I need to be on a Zoom with my kids, that doesn't mean you're not serious about your job or not doing your job well," she said. "We want to reduce this perception bias."

This is particularly important to maintain equity and diversity within an organization, Rangamani added. "We need to be extremely vigilant to ensure that those who are particularly vulnerable do not exit the system," she said. Single parents, those who are taking care of elderly parents and relatives, and parents whose children have special services are especially at risk, she added. "The intense pressure of being 'on' all the time is simply not realizable right now."

While the paper outlines some changes that can be made at a campus-wide or even university system level, Rangamani is focused on a smaller scale: an office or a department for example. It is much easier to get these smaller groups together and have genuine conversations about what the individual needs are and what can be done to get our colleagues through this intensely difficult period without sacrificing quality or fairness.. "There are measures you can take at the grassroots level," she said.

In order to normalize these conversations about work-life balance Rangamani hopes that leadership will empower those who hesitate to ask for help to do so.
Here are the 10 suggestions that the paper outlines to cope during the pandemic:

Find a peer group of women to provide professional support.
"The authors are all members of an online group for women PIs in biomedical engineering, which has historically served as a sounding board for professional concerns. We have found that maintaining these connections has been essential over the course of our careers and are even more important during this quarantine period."

Say no to requests to do anything outside of your main responsibilities
"If you can't do them now, you can offer a time when you might be able to do them; the requesting party will need to recognize that your future schedule could go through upheaval as surges of the disease hit different areas and restrictions change. "

Drop something
"True, your house might not be as clean as you would like, and you may be eating more frozen pizza than you normally would tolerate. Remember that you are not the only person accepting this as your "new normal." We can't forget that the goal during a pandemic is survival--if you are keeping yourself physically and mentally healthy, you are more than succeeding."

When you have energy to do more than the minimum, use it to support women and underrepresented groups
"We recognize that advocacy of this nature is a privilege, and not everyone is able to do so safely. If you are in the position to support women and underrepresented groups and have the energy, pick a cause and lean into it. Also, recognize that this action can take many forms, some of which may be a better fit for your individual situation."

Remember, you know yourself best
"You know the things that have historically helped you relieve stress. Make a list of 10 of them. Some of them may not be an option during quarantine (oh, how some of us miss writing in coffee shops). But for those that are an option, try to do 1 of them every now and then."

It's OK to push back
"Perpetuating the myth that we can all work to the same degree (or better!) than we did a few months ago is very damaging to many women PIs. When you hear statements such as "everyone is writing more grants now" and "since we have more time, let's have a virtual conference about this topic," it's more than OK to push back that this is not your reality, regardless of the reason."

Remember, you have some flexibility to make your own schedule
"If there are pockets of time where you find yourself able to focus better than others, do your best to protect them. Block these times on your calendar--both in the near future and in the upcoming months by declining invitations for extraneous responsibilities."

Whatever help you can get, take it
"Perhaps your kids are old enough that they can even help with some of your work--1 of the authors tried (unsuccessfully) to engage her son in doing analysis on ImageJ (NIH, Bethesda, Maryland). Another purchased a 3D printer and recruited her daughter to help print parts for an OpenSPIM setup."

Do your best to remember that others are struggling too--be empathetic and work to build a community
"We suggest that each situation is approached with empathy, while maintaining your standards and accountability. For example, empathy may mean that when you assign a task to a group member or staff, you ask them whether the timeline is feasible. If it's not, that may be a sign that in the future you should aim to give them more advance notice. If a pattern of not completing work continues, it is then time to ask for an explanation. Recognize that just as no one is fully aware of your situation, you are not completely aware of your colleague's situation."

Don't lose your sense of humor
"We know, there is nothing funny about this situation. Many of us have needed or will need space to grieve deeply. However, our experience is that where you can share a laugh, you should."

Rangamani herself does her best to implement some of these suggestions. She prioritizes the well-being of her own research group over other zoom meetings; protects her research time; and does not schedule meetings at lunch time, if she can help it.

"While there is a light at the end of the tunnel in the form of vaccines," Rangamani also notes, "this global health crisis may be a once-in-a-lifetime opportunity for the academy to take a close look at how we can empower our vulnerable colleagues and make policy changes to change our culture for the better."

The authors put rule, or rather suggestion, 10 in practice, by including a list of humorous rules and tips in a supplemental file.

"Service expectations are now completely fulfilled by raising scientifically literate humans of our own and science communication by way of family conversations, Facebook and Twitter debates," they write.

Credit: 
University of California - San Diego

How the brain learns that earmuffs are not valuable at the beach

image: A collaboration between the University of Tsukuba and the NEI in the US has discovered that fast-spiking neurons in the basal ganglia allow monkeys to associate different values with the same objects based on the surrounding environment. Blocking input from these cells inhibited learning of new scene-based values, but did not erase already learned associations. This could help understand clinical conditions such as Tourette syndrome, which is characterized by reduced input from these cells.

Image: 
University of Tsukuba

Tsukuba, Japan -- How valuable are earmuffs? The answer to this simple question can depend. What brand are they? Are they good quality? What is the weather like? Given the choice between earmuffs and suntan lotion, most people would choose to have the earmuffs on a cold winter day and the lotion on a sunny day at the beach. This ability to place different values on objects depending on the environmental context is something that we do all the time without much thought or effort. But how does it work? A new study led by Assistant Professor Jun Kunimatsu at the University of Tsukuba in Japan and Distinguished Investigator Okihide Hikosaka at the National Eye Institute (NEI) in the United States has discovered the part of the brain that allows this type of learning to occur.

"Value and reward are known to be encoded in the part of the brain called the basal ganglia," explains Dr. Hikosaka. "We set out to identify the specific neuronal circuits underlying environment-based value learning."

To find the answer, the researchers first taught monkeys a kind of "Where's Waldo" game in which they searched scenes for embedded objects that gave them rewards. Looking at the objects could lead big or small rewards depending on the background scene in which they were embedded. After the monkeys learned this game using many objects and many backgrounds, they were able to routinely make eye movements to the big rewards and avoid looking at the small rewards, even when the background scenes were switched suddenly.

The final output from the basal ganglia controls motor movements, in this case eye movements. The team hypothesized that a certain kind of brain cell called fast-spiking neurons were responsible for the successful learning of their game. To test this idea, they used a drug to temporarily block input from these cells to different parts of the basal ganglia just when monkeys were trying to learn the associations between objects, backgrounds, and values. They found that when input to the tail end of the striatum--a part of the basal ganglia-- was blocked, it prevented monkeys from learning new scene-based associations, but did not prevent them from performing well when they were given scenes and objects that they had already learned.

The findings could have applications in clinical research. "Reduced input from fast-spiking neurons has been observed in some clinical conditions," says Dr. Kunimatsu, "including Tourette syndrome and Huntington's disease, both of which are accompanied by deficits in skill learning that could be related to an inability to learn environment-based values."

Credit: 
University of Tsukuba

Study results show COVID-19 virus triggers antibodies from previous coronavirus infections

The results of a study led by Northern Arizona University and the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest the immune systems of people infected with COVID-19 may rely on antibodies created during infections from earlier coronaviruses to help fight the disease.

COVID-19 isn't humanity's first encounter with a coronavirus, so named because of the corona, or crown-like, protein spikes on their surface. Before SARS-CoV-2 -- the virus that causes COVID-19 -- humans have navigated at least 6 other types of coronaviruses.

The study sought to understand how coronaviruses (CoVs) ignite the human immune system and conduct a deeper dive on the inner workings of the antibody response. The published findings, "Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses," appear today in the journal Cell Reports Medicine.

"Our results suggest that the COVID-19 virus may awaken an antibody response that existed in humans prior to our current pandemic, meaning that we might already have some degree of pre-existing immunity to this virus." said John Altin, an assistant professor in TGen's infectious disease branch and the study's senior author.

This knowledge could help researchers design new diagnostics, evaluate the healing powers of convalescent plasma, develop new therapeutic treatments and -- importantly -- help design future vaccines or monoclonal antibody therapies capable of protecting against mutations that may occur in the COVID-19 virus.

The researchers used a tool called PepSeq to finely map antibody responses to all human-infecting coronaviruses. PepSeq is a novel technology being developed at TGen and NAU that allows for the construction of highly diverse pools of peptides (short chains of amino acids) bound to DNA tags. When combined with high-throughput sequencing, these PepSeq molecule pools allow for deep interrogation of the antibody response to viruses.

"The data generated using PepSeq allowed for broad characterization of the antibody response in individuals recently infected with SARS-CoV-2 compared with those of individuals exposed only to previous coronaviruses that now are widespread in human populations," said Jason Ladner, the study's lead author and an assistant professor in NAU's Pathogen and Microbiome Institute.

Besides SARS-CoV-2, researchers examined the antibody responses from two other potentially deadly coronaviruses: MERS-CoV, which caused the 2012 outbreak in Saudi Arabia of Middle East Respiratory Syndrome; and SARS-CoV-1, the first pandemic coronavirus that caused the 2003 outbreak in Asia of Severe Acute Respiratory Syndrome. All three are examples of coronaviruses that infect animals, but evolved to make people sick and became new human pathogens.

In addition to characterizing antibodies that recognize SARS-CoV-2, they also examined the antibody responses of four older coronaviruses: alphacoronavirus 229E; alphacoronavirus NL63; betacoronavirus OC43; and betacoronavirus HKU1. These so called "common" coronaviruses are endemic throughout human populations, but usually are not deadly and cause mild upper respiratory infections similar to those of the common cold.

By comparing patterns of reactivity against these different coronaviruses, the researchers demonstrated that SARS-CoV-2 could summon immune system antibodies originally generated in response to past coronavirus infections. This cross-reactivity occurred at two sites in the SARS-CoV-2 Spike protein; the protein on the surface of virus particles that attaches to ACE2 proteins on human cells to facilitate cell entry and infection.

"Our findings highlight sites at which the SARS-CoV-2 response appears to be shaped by previous coronavirus exposures, and which have potential to raise broadly-neutralizing antibodies. We further demonstrate that these cross-reactive antibodies preferentially bind to endemic coronavirus peptides, suggesting that the response to SARS-CoV-2 at these regions may be constrained by previous coronavirus exposure," said Altin, adding that more research is needed to understand the implications of these findings.

The findings could help explain the widely varying reactions COVID-19 patients have to the disease; from mild to no symptoms, to severe infections requiring hospitalization, and often resulting in death. It's also possible that differences in the pre-existing antibody response identified by this study could help to explain some of the difference in how severely COVID-19 disease manifests in old versus young people, who will have different histories of infections with the common coronaviruses.

"Our findings raise the possibility that the nature of an individual's antibody response to prior endemic coronavirus infection may impact the course of COVID-19 disease," Ladner said.

Also contributing to this study were: City of Hope National Medical Center, Walter Reed National Military Medical Center, Vitalant Research Institute, Sanford Burnham Prebys Medical Discovery Institute, Norwegian University of Science and Technology, St. Olavs Hospital and Encodia Inc.

Former undergraduate computer science student Zane Fink is named a co-author of the study. "Zane helped a lot with the design of the assays used and he wrote custom analysis software," said Ladner. Fink, who graduated from NAU in Spring 2020, is now pursuing a PhD in computer science at the University of Illinois.

Funding for this study was provided by the National Institutes of Health and the State of Arizona Technology and Research Initiative Fund.

# # #

About Northern Arizona University
Northern Arizona University is a higher-research institution providing exceptional educational opportunities in Arizona and beyond. NAU delivers a student-centered experience to its nearly 30,000 students in Flagstaff, statewide and online through rigorous academic programs in a supportive, inclusive and diverse environment. Dedicated, world-renowned faculty help ensure students achieve academic excellence, experience personal growth, have meaningful research opportunities and are positioned for personal and professional success.

About TGen, an affiliate of City of Hope
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based nonprofit organization dedicated to conducting groundbreaking research with life-changing results. TGen is affiliated with City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases: CityofHope.org. This precision medicine affiliation enables both institutes to complement each other in research and patient care, with City of Hope providing a significant clinical setting to advance scientific discoveries made by TGen. TGen is focused on helping patients with neurological disorders, cancer, diabetes and infectious diseases through cutting-edge translational research (the process of rapidly moving research toward patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and complex rare diseases in adults and children. Working with collaborators in the scientific and medical communities worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, visit: tgen.org. Follow TGen on Facebook, LinkedIn and Twitter @TGen.

Media Contact:
Steve Yozwiak
TGen Senior Science Writer
602-343-8704
syozwiak@tgen.org

Credit: 
Northern Arizona University

When it comes to eyewitness accounts of earthquake shaking, representation matters

As scientists increasingly rely on eyewitness accounts of earthquake shaking reported through online systems, they should consider whether those accounts are societally and spatially representative for an event, according to a new paper published in Seismological Research Letters.

Socioeconomic factors can play a significant if complex role in limiting who uses systems such as the U.S. Geological Survey's "Did You Feel It?" (DYFI) to report earthquake shaking. In California, for instance, researchers concluded that DYFI appears to gather data across a wide socioeconomic range, albeit with some intriguing differences related to neighborhood income levels during earthquakes such as the 1989 Loma Prieta, the 1994 Northridge and 2018 Ridgecrest earthquakes.

In India, by contrast, stark gaps in literacy and urban versus rural communities can lead to gaps in self-reported earthquake accounts though DYFI, write Susan Hough of the USGS and Stacey Martin of Australian National University.

Previous studies have looked at the reasons why people respond to DYFI, including a 2016 publication by Sum Mak and Danijel Schorlemmer. But socioeconomic differences in who reports earthquake shaking "is a factor we haven't thought enough about, even though it is shaping the data sets that are available, especially outside of the United States" said Hough.

Intensity data gleaned from DYFI are used to develop ShakeMap representations of ground motion in places with sparse instrumentation. ShakeMap in turn informs the Prompt Assessment of Global Earthquakes for Response (PAGER) system that provides crucial rapid information for earthquake response.

"The end result is that we are relying on unrepresentative [DYFI] data to flesh out ShakeMaps for large global earthquakes," Hough noted. "If the data are limited and unrepresentative, PAGER may not give emergency managers a good indication of where to direct their resources."

"I know many who take the DYFI observations from outside the United States at face value without any scrutiny and made the incorrect assumption that that's all there is to the story," Martin added. "As we've shown in this study, that would be a really inappropriate assumption."

Representation can also come into play when scientists rely on archival accounts to study historic earthquakes. Hough described the potential impact of unrepresentative earthquake reports in an earlier study when she and her colleague Morgan Page found a letter published in an Arkansas newspaper that helped to re-locate an 1882 earthquake within the Choctaw Nation in southeastern Oklahoma. The single chance account has helped seismologists better understand historical seismicity in Oklahoma, but there are still many "unknown unknowns" about earthquakes in the region during and after the 1882 event because Native American accounts are unavailable, Hough said.

When Hough and Martin compared DYFI responses with ZIP code average household income for the three California earthquakes, the researchers uncovered some complex and intriguing trends. For the Northridge earthquake, for instance, relatively affluent areas were more likely to contribute strong shaking reports, and strong shaking levels from poorer areas may be underrepresented in the DYFI data.

The researchers found that in India, DYFI reports skewed heavily toward urban individuals and depended strongly on a region's literacy rates. In some cases, the difference between DYFI self-reports and accounts gathered through traditional means such as local press accounts was significant. For the 2015 Gorkha earthquake, for instance, 74% of DYFI responses were from urban areas, while only 34% of traditional accounts were from urban centers.

"Being Indian, I know firsthand that there are disparities on numerous fronts in my country," said Martin. "Nonetheless the stark contrast in urban and rural DYFI reports from India for the three earthquakes that were analyzed for this study was still surprising to me. I did not anticipate that the social disparities would show up in something as seemingly far removed as earthquake felt reports."

Further development of online systems will potentially make them more inclusive; for example, including online surveys in multiple languages, and designing easy-to-use apps. It also remains important, the researchers said, to survey earthquake effects using media reports, which the study showed tend to be more inclusive in India.

Hough noted that the geoscience community is grappling with how underrepresentation affects its workforce, but studies like this show how underrepresentation "is actually an issue for science itself."

"You can connect the dots, I think," she said. "If you don't have a diverse community of scientists, you don't have people who are asking the right questions."

Credit: 
Seismological Society of America

Abandoned cropland should produce biofuels

Growing perennial grasses on abandoned cropland has the potential to counteract some of the negative impacts of climate change by switching to more biofuels, according to a research group from the Norwegian University of Science and Technology (NTNU).

Researchers consider increased use of biofuels to be an important part of the solution to reduce CO2 emissions. But the production of plants for biofuels can have some unfortunate trade-offs.

Now, the NTNU researchers have come up with a scenario that would put less pressure on food production and plant and animal life.

"We can grow perennial grasses in areas that until recently were used for growing food but that are no longer used for that purpose," explains Jan Sandstad Næss, a PhD candidate at the Industrial Ecology Programme at NTNU. These areas are usually still potentially cultivable and have the advantage that they are already connected to farms, which means that the infrastructure is in place and they are close to markets.

The results from the study have now been published in Nature Sustainability.

Biofuels come in several varieties. Common to all is that plants are broken down and transformed into a product we can use as fuel in vehicles and machines, for example.

But corn, wheat, rapeseed and soybeans that become biofuels instead of food affect people's ability to feed themselves, making the choice for biofuels ethically questionable. Wild areas cleared to grow biofuels can compromise biodiversity.

In many of the scenarios that the researchers explored, the production of biofuels would not compete with food production or wilderness, but would use cropland that has been abandoned due to more efficient food production or because plant foods replace more land-intensive meat production.

The least controversial option for producing biofuels is the use of waste from industry, agriculture and forestry, but this does not generate nearly enough biofuel.

If we use areas that already have limited value for other purposes, the cultivation of biofuels will become more attractive for more people.

Until now, no one has calculate the extent of areas available for this type of grass cultivation. Næss and his colleagues Professor Francesco Cherubini and researcher Otávio Cavalett investigated the question by examining satellite images from around the world. Cherubini is also director of NTNU's Industrial Ecology Programme.

"We found 83 million hectares, or 830 000 square kilometres, of areas that until recently were used for food production but now no longer are," Sandstad Næss said.

These locations roughly correspond to the land area of Sweden and Norway combined, including Svalbard, or the equivalent of five per cent of the area currently used for food production worldwide.

These are areas that have been heavily affected by humans, so many species are already gone. Grass production could increase biodiversity.

The research group believes that most of these areas can be used to grow perennial grasses for biofuels instead of leaving them unused by humans. However, there is a large variation in how much this can cover of future biofuel demand.

Biofuel production on abandoned cropland "could provide the energy equivalent of between 6 and 39 exajoules each year. This corresponds to between 11 and 68 per cent of today's bioenergy needs and 2 to 47 per cent of the production of biofuels in 2050, given the assumption that we limit the temperature increase to 1.5 degrees Celsius," says Cavalett.

How much biofuel people can grow depends on many local factors and on how the areas are managed. Negative environmental impacts need to be weighed against the need for energy.

"We could generate around 20 exajoules every year if we increase land area by only 3 per cent and water use by 8 per cent. That scenario would mean we wouldn't disturb areas that are especially critical for biodiversity or that require a lot of irrigation," says Cherubini.

The researchers believe that growing perennial grasses for biofuels would simultaneously revitalize rural areas and provide more sources of income for farmers.

But this option won't happen by itself. Communities need to determine local climatic conditions and water availability, as well as local value chains and what kind of grass is best to grow there. These decisions therefore require that local and regional authorities collaborate to implement such a plan.

Credit: 
Norwegian University of Science and Technology

Estrogen receptors in mom's placenta critical during viral infection

image: Human placental cells were stained to indicate the presence of an estrogen receptor called GPER1, which helps protect the fetus from the immune response to viral infection. (Scale bar 75 micrometers)

Image: 
Nicholas Heaton Lab, Duke University

DURHAM, N.C. - Researchers at Duke and Mt. Sinai have identified a molecular mechanism that prevents a viral infection during a mother's pregnancy from harming her unborn baby.

When a person becomes infected by a virus, their immune system sends out a chemical signal called type I interferon, which tells surrounding cells to increase their anti-viral defenses, including making more inflammation.

This response helps to prevent the virus from copying itself and gives the adaptive immune system more time to learn about the new invader and begin to hunt it down.

A pregnant woman who encounters a virus generates these same signals to protect herself, but if those signaling molecules and the resulting inflammation were able to cross the placenta and reach the fetus, they would lead to serious developmental abnormalities and even fetal death.

But this generally doesn't happen, except for the Zika virus and a handful of other viruses known to replicate inside the fetus and harm it. (Despite almost 100 million reported cases of COVID-19 to date around the world, there is no strong evidence that the virus which causes the disease, SARS-CoV-2, poses a threat to fetuses.)

The research team found a mechanism that protects the fetus from the harm the mother's immune response to a virus could cause. In a paper appearing Jan. 15 in Science, they identify a key player in this pathway as a cell-surface estrogen receptor called GPER1 that is especially abundant in the placenta and fetal tissues.

"This likely explains why many maternal infections during pregnancy don't hurt the fetus," said study leader Nicholas Heaton, an assistant professor of Molecular Genetics and Microbiology in the Duke School of Medicine.

Having arrived at GPER1 as a possible candidate for this effect by a series of screens, the researchers found GPER1 receptors concentrated in the placenta, where the mother's blood supply passes oxygen and nutrients over to the fetus. Estrogen levels are much higher during pregnancy, making the GPER1 receptor even better able to suppress interferon signaling in the placenta and developing fetus.

The researchers tried blocking this particular estrogen receptor in pregnant mice with a compound called G15. They found changes in the placenta during influenza A virus infection or G15 treatment, which led to slightly smaller mouse pups. But with both G15 and influenza virus present, the pups were dramatically smaller and many were stillborn.

They also tested mouse pregnancies with Zika and influenza B virus infections and saw that the addition of the G15 treatment again led to many more fetal defects.

"If we disable the GPER1 pathway, even normally benign maternal infections (like flu) will now cause major fetal developmental issues," Heaton said.

Heaton calls it a pathway because his team doesn't yet understand how GPER1 provides this protection. They suspect the receptor triggers other downstream mechanisms that come into play.

Heaton said the beauty of this system being concentrated around the baby is that it protects the fetus from inflammation, while leaving the rest of the mother's tissues more able to use interferon to fight the virus.

The researchers are next going to pursue tests of whether "hyperactivating" the GPER1 pathway would be a way to protect fetal development when a mother becomes virally infected.

Credit: 
Duke University

Smooth touchdown: novel camera-based system for automated landing of drone on a fixed spot

image: A standard radio control-based drone, upgraded with necessary hardware and software and equipped with a simple 2D camera for the detection of a symbolized landing pad

Image: 
Malik Demirhan and Chinthaka Premachandra in "Development of an Automated Camera-Based Drone Landing System," published in IEEE Access by IEEE Xplore, under Creative Commons license CC BY-NC-ND 4.0

Initially earmarked for covert military operations, unmanned aerial vehicles (UAVs) or drones have since gained tremendous popularity, which has broadened the scope of their use. In fact, "remote pilot" drones have been largely replaced by "autonomous" drones for applications in various fields. One such application is their usage in rescue missions following a natural or man-made disaster. However, this often requires the drones to be able to land safely on uneven terrain--which can be very difficult to execute.

"While it is desirable to automate the landing using a depth camera that can gauge terrain unevenness and find suitable landing spots, a framework serving as a useful base needs to be developed first," observes Dr. Chinthaka Premachandra from Shibaura Institute of Technology (SIT), Japan, whose research group studies potential applications of camera-based quadrocopter drones.

Accordingly, Dr. Premachandra and his team set out to design an automatic landing system; they have detailed their approach in their latest study published in IEEE Access. To keep things simple, they upgraded a standard radio control (RC)-based drone with necessary hardware and software and equipped it with a simple 2D camera for the detection of a symbolized landing pad.

"The challenges in our project were two-fold. On the one hand, we needed a robust and cost-effective image-processing algorithm to provide position feedback to the controller. On the other, we required a fail-safe switch logic that would allow the pilot to abort the autonomous mode whenever required, preventing accidents during tests," explains Dr. Premachandra.

Eventually, the team came up with a design that comprised the following components: a commercial flight controller (for attitude control), a Raspberry Pi 3B+ (for autonomous position control), a wide-angle modified Raspberry Pi v1.3 camera (for horizontal feedback), a servo gimbal (for camera usage control), a Time-of-Flight (ToF) module (as feedback sensor for the drone height), a multiplexer (for switching between manual and auto modes), an "anti-windup" PID controller (for height control), and two PD controllers (for horizontal movement control).

In addition, they implemented an image-processing algorithm that detected a distinctive landing symbol (in the shape of "H") in real time and converted the image pixels into physical coordinates, which generated a horizontal feedback. Interestingly, they found that introducing an adaptive "region of interest" helped speed up the computation of the camera's vertical distance to the landing symbol, greatly reducing the computing time--from 12-14 milliseconds to a meagre 3 milliseconds!

Following detection, the system accomplished the landing process in two steps: flying towards the landing spot and hovering over it while maintaining the height, and then actually landing vertically. Both these steps were automated and therefore controlled by the Raspberry Pi module.

While examining the landing, the research team noticed a disturbance in landing behavior, which they attributed to an aerodynamic lift acting on the quadrocopter. However, this problem could be overcome by boosting the gain of the PID controller. In general, performance during the landing process indicated a properly functioning autonomous system.

With these results, Dr. Premachandra and his team look forward to upgrading their system with a depth camera and thus enabling drones to find even more applications pertaining to daily life. "Our study was primarily motivated by the application of drones in rescue missions--But it shows that drones can, in future, find use in indoor operations such as indoor transportation and inspection, which can reduce a lot of manual labor," concludes Prof. Premachandra.

Credit: 
Shibaura Institute of Technology

COVID-19 virus helps block host immunity

image: Covers all aspects of interferons and cytokines from basic science to clinical applications.

Image: 
Mary Ann Liebert, Inc., publishers

New Rochelle, NY, January 20, 2020--SARS-CoV-2, the virus that causes COVID-19, blocks the processes of innate immune activation that normally direct the production and/or signaling of type I interferon (IFN-I) by the infected cell and tissues. IFN-I is a key component of host innate immunity that is responsible for eliminating the virus at the early stage of infection, as summarized in a recent review article in Journal of Interferon & Cytokine Research (JICR). By suppressing innate immunity, the virus replicates and spreads in the body unchecked, leading to the disease known as COVID-19. Click here to read the article now.

"SARS-CoV-2 utilizes various approaches to evade host IFN-I response, including suppression of IFN-I production and IFN-I signaling," state Hongjie Xia and Pei-Yong Shi, University of Texas Medical Branch at Galveston. "Viruses defective in antagonizing IFN-I response, in combination with replication-defective mutations, could potentially be developed as live attenuated vaccine candidates."

"Targeting innate immunity is highly attractive for therapeutic and vaccine strategies aimed at controlling SARS-CoV-2 infection and protecting against COVID-19. By revealing how the virus blocks innate immune programs we can then build approaches to restore these processes and enhance antiviral immunity," says Journal of Interferon & Cytokine Research Editor-in-Chief Michael Gale Jr., Department of Immunology and Center for Innate Immunity and Immune Disease, University of Washington.

Other COVID-related articles in this issue of Journal of Interferon & Cytokine Research include a review by Benjamin Liu and Harry Hill on the role of host immune and inflammatory responses in COVID-19 cases with underlying primary immunodeficiency. Primary immunodeficiency patients are highly vulnerable to virus infections including SARS-CoV-2. The authors conclude that routine intravenous immunoglobulin therapy may provide some protective effects to patients with primary immunodeficiency.

Ricardo Pereda and coauthors explore the therapeutic effectiveness of interferon alpha 2b treatment for COVID-19 patient recovery. They showed that interferon treatment decreases the likelihood of intensive care stay and increases patient survival after severe or critical disease.

Credit: 
Mary Ann Liebert, Inc./Genetic Engineering News

The interconnection of global pandemics -- Obesity, impaired metabolic health and COVID-19

image: Obesity and cardiometabolic diseases do not only trigger a more severe course of COVID-19, the SARS-CoV-2 infection could promote the development of these conditions.

Image: 
Norbert Stefan

In a Nature Reviews Endocrinology article authors from the German Center for Diabetes Research (DZD) highlight the interconnection of obesity and impaired metabolic health with the severity of COVID-19. First, they provide information about the independent relationships of obesity, disproportionate fat distribution and impaired metabolic health with the severity of COVID-19. Then they discuss mechanisms for a complicated course of COVID-19 and how this disease may impact on the global obesity and cardiometabolic pandemics. Finally, they provide recommendations for prevention and treatment in clinical practice and in the public health sector to combat these global pandemics.

Norbert Stefan, Andreas Birkenfeld and Matthias Schulze summarize and discuss data from large and well-performed studies that investigated independent relationships of obesity with the severity of COVID-19. Thereby, they can disentangle the contribution of obesity, visceral fatness and impaired metabolic health for the course of COVID-19. In this respect they found convincing evidence that obesity and overt diabetes, but also visceral obesity and even mild hyperglycemia, represent important risk factors for the disease course. Thus, these risk factors most probably may have an additive effect on the severity of COVID-19.

Then they discuss the impact of the SARS-CoV-2 infection on organ function, focusing on the cardiometabolically relevant tissues and organs as the vessel wall, heart, kidneys, liver, gut and pancreas. Thereby, they address both, the immediate damage of COVID-19 to the organs and the long-term effects of the disease, most probably boosting the development of obesity and cardiometabolic diseases. Thus, obesity and cardiometabolic diseases do not only trigger a more severe course of COVID-19, the SARS-CoV-2 infection does promote the development of these conditions.

The authors further highlight how treatment of obesity and impaired cardiometabolic health helps to avert a severe COVID-19 in patients infected with SARS-CoV-2. In this respect health professionals and politicians should now, more than ever, promote the health benefits of physical activity and support efforts to implement programmes and policies to facilitate increased physical activity and to promote a healthy diet. This might not only be relevant to directly reduce the burden of COVID-19 related morbidity and mortality among those infected, but may also be important in the context of SARS-CoV-2 vaccination, where response should be carefully evaluated in patients with obesity and/or diabetes mellitus, because of a potentially reduced or shortened response.

Credit: 
Deutsches Zentrum fuer Diabetesforschung DZD

Important cause of preeclampsia discovered

image: The results of many years of research have been a long time coming. Gabriela Silva (in the white labocoat) used tissue samples from a biobank, including placenta samples from 90 women with preeclampsia obtained immediately after birth. The samples were examined using advanced microscopes.

Image: 
Photo: NTNU

Despite being the subject of increasing interest for a whole century, how preeclampsia develops has been unclear - until now.

Researchers believe that they have now found a primary cause of preeclampsia.

"We've found a missing piece to the puzzle. Cholesterol crystals are the key and we're the first to bring this to light," says researcher Gabriela Silva.

Silva works at the Norwegian University of Science and Technology's (NTNU) Centre of Molecular Inflammation Research (CEMIR), a Centre of Excellence, where she is part of a research group for inflammation in pregnancy led by Professor Ann-Charlotte Iversen.

The findings are good news for the approximately three per cent of pregnant women in Norway who get this disease. Worldwide, preeclampsia is a leading cause of illness and death in both mother and foetus.

In a preeclamptic pregnancy, the placenta does not develop properly, and the baby sometimes also receives too little nutrition.

The symptoms of preeclampsia are often mild, but in some cases the condition becomes so severe that the baby needs to be delivered prematurely.

Preeclampsia does not disappear until the baby is born. Since no one has understood why the condition occurs, the current treatment is to monitor and alleviate the symptoms.

Silva believes that future treatment will now become more effective.

"A pregnancy is actually a kind of natural inflammatory condition, and in the case of preeclampsia, the inflammation has become too strong and leads to disease," Silva says.

Women who have had preeclampsia have an increased risk of developing cardiovascular disease later in life.

It was precisely this connection that led the researchers to choose to examine cholesterol in pregnant women with preeclampsia. Cholesterol is a major cause of cardiovascular disease.

Cholesterol crystals are found in plaque that clogs blood vessels. The crystals are formed when bad cholesterol accumulates in the blood vessel walls. Studies have shown that cholesterol crystals are a particularly powerful initiator of inflammation in the body and can cause the blood to clot.

Cholesterol crystals are identified as harmful substances in the body that need to be cleared out. But the defence cells that come in to do the job aren't able to break them down. They call for reinforcements, and more immune cells come in, to no avail. The immune response runs wild, and the inflammatory process escalates.

Silva found that the inflammation was at its highest in the region called the maternal-foetal interface, where the mother's cells come into direct contact with foetal cells. This happens in the placenta and uterine wall.

"This direct contact means that the inflammation directly affects the communication between mother and foetus and contributes to even greater inflammation in the mother," says Silva.

Cholesterol levels are high in all pregnant women, because both the foetus and the placenta need cholesterol. But levels were even higher in women with preeclampsia. They also had much more of the bad cholesterol, which is the type of cholesterol found in people who are at high risk for cardiovascular disease.

Silva went to great lengths to solve the riddle. She used tissue samples from a biobank that the research group at CEMIR has built up, and included placenta samples from 90 women with preeclampsia obtained immediately after birth. The researchers therefore had tissue samples from both the uterine wall and the placenta. The samples were examined using advanced microscopes.

It has taken years of research to arrive at the result.

Future treatment for preeclampsia may simply include cholesterol-lowering medications, such as statins, but further research is needed to clarify their effects.

"Some women have an increased risk of preeclampsia right from the start. They should be followed up with a cholesterol check. This isn't done regularly today, but it should be done regularly in the future. The use of statins during pregnancy is not recommended now, but several clinical studies are looking more closely at this and are showing that pravastatin, for example, can be safe to use during pregnancy," says Silva.

Credit: 
Norwegian University of Science and Technology

Gastrointestinal surgery can be a cure for type 2 diabetes finds new long-term study

The results of a randomised clinical trial with the longest follow up to date show that metabolic surgery is more effective than medications and lifestyle interventions in the long-term control of severe type 2 diabetes.

The study, published today in The Lancet, also shows that over one-third of surgically-treated patients remained diabetes-free throughout the 10-year period of the trial. This demonstrates, in the context of the most rigorous type of clinical investigation, that a "cure" for type 2 diabetes can be achieved.

Researchers from King's College London and the Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy report the 10-year outcomes of a trial that compared metabolic surgery with conventional medical and lifestyle interventions in patients with type 2 diabetes.

The study involved 60 patients with advanced type 2 diabetes and treated at a major academic hospital in Rome, Italy. The patients randomly underwent drugs plus lifestyle interventions or metabolic surgery (gastric bypass or biliopancreatic diversion). At the start of the study, all patients had severe disease, with poorly controlled blood sugar levels and more than five years history of diabetes.

The results of the study show that 37.5% of surgically-treated patients were able to maintain non-diabetic glycaemia without need for diabetes medication - a condition referred to as diabetes remission - for the duration of the 10-year study period. In 2009, American Diabetes Association defined "cure" of diabetes as a continued state of disease remission for more than five years.

Professor Francesco Rubino, senior author of the report and Chair of Bariatric and Metabolic Surgery at King's College London and a consultant surgeon at King's College Hospital in London said: "The findings from this study provide the most robust scientific evidence yet that full-blown type 2 diabetes is a curable disease, not inevitably progressive and irreversible. In addition to represent a major advance in the treatment of diabetes, metabolic surgery is our best lead to the elusive cause of the disease".

Compared to conventional medical treatment, surgery also resulted in better overall metabolic control, lower cardiovascular risk, better kidney function and quality of life. Notably, patients treated surgically had a significant lower incidence of diabetes-related complications, including cardiac, renal, and neurological adverse events. Metabolic surgery also reduced medication usage, including drugs for diabetes, high blood pressure and dyslipidaemia.

The study investigated the early and long-term safety of the different intervention strategies. Patients who underwent biliopancreatic diversion had more incidences of serious adverse events, including events associated to both disease and intervention, compared to subjects in both other groups. Patients treated by conventional medical therapy had significantly higher incidence of serious adverse events compared to patients who underwent surgery by Roux-en-Y gastric bypass.

Professor Geltrude Mingrone, first author of the report, Professor of Medicine at the Catholic University of Rome and a Professor of Diabetes and Nutrition at King's College London said: "These data corroborate the notion that surgery can be a cost-effective approach to treating type 2 diabetes. The evidence is now more than compelling that metabolic surgery should be considered as a main therapeutic option for the treatment of patients with severe type 2 diabetes and obesity."

Previous studies had shown that bariatric or weight loss surgery can induce long-term remission of diabetes in patients with very severe obesity; however, most patients who undergo traditional weight loss surgery have typically mild or recent-onset diabetes. This trial shows the potential curative effect of metabolic surgery for patients with severe disease.

Diabetes is one of the leading causes of mortality and morbidity in Western societies and significantly increases the risk of severe COVID-19 and mortality from the virus. Despite the evidence that surgery can rapidly and dramatically improve diabetes, less than 1% of surgical candidates have access to metabolic surgery in most countries. Furthermore, metabolic surgery operations have been suspended for even longer than other elective surgical procedures during the current pandemic.

Professor Rubino added: "Metabolic surgery is arguably the most effective available therapy for type 2 diabetes and can be a life-saving option for many patients. It should be appropriately prioritized in times of pandemic and beyond."

Credit: 
King's College London